Use of 15-methyl prostaglandin F2 alpha postpartum to contract the uterus in normal pregnant women.
D002260:Carboprost / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D011247:Pregnancy; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*; D014590:Uterine Contraction / Q000187:drug effects*; D014593:Uterine Inertia / Q000188:drug therapy*
D011461:Prostaglandins F, Synthetic; D002260:Carboprost